Monday, 3 August 2020

Serum gets DCGI nod for Phase 2 & 3 trials

India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.

from The Times of India https://ift.tt/2PyOxrD
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Ukraine's drone commander has Russian oil, troops and morale in his sights

In a rare interview, Commander Robert Brovdi shared how his unit accounts for a third of all targets destroyed on the battlefield. from BB...